Clinical Trial Update: Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and efficacy trial of umbilical cord-derived mesenchymal stem cells for rheumatoid arthritis; sponsored by Alliancells Bioscience Corporation L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Alliancells Bioscience Corporation Limited | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: UNKNOWN